GIA
NDRA icon

Gladstone Institutional Advisory’s ENDRA Life Sciences NDRA Stock Holding History

Gladstone Institutional Advisory’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed -$15K – 313
2020
Q3 		$15K Hold
1
– – ﹤0.01% 269
2020
Q2 		$35K Buy
+1
New +$29K 0.01% 238

Other funds holding NDRA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gladstone Institutional Advisory's NDRA Position: Q4 2020 in Review

Gladstone Institutional Advisory sold out of ENDRA Life Sciences (NDRA) in Q4 2020, closing a stake of 1 share — an estimated $15K sold.

Gladstone Institutional Advisory first reported a position in NDRA in Q2 2020 and held it in 2 quarters. The position peaked at $35K in Q2 2020. 11 funds tracked by Wall St. Rank hold NDRA as of Q4 2020.

  • Gladstone Institutional Advisory reported no remaining ENDRA Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 1 ENDRA Life Sciences share in Q4 2020, an estimated $15K.
  • Gladstone Institutional Advisory first reported a position in ENDRA Life Sciences in Q2 2020 and held it in 2 quarters.
  • Gladstone Institutional Advisory's ENDRA Life Sciences position peaked at $35K in Q2 2020.
  • 11 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2020.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2020, filed 16 Feb 2021.